(Q58327145)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

title

Treatment of osteoporosis in children with glucocorticoid-treated diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Graziana Colaianni

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Maria Grano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

author name string

Vincenza Luce

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Antonella Lonero

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Annamaria Ventura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Giacomina Brunetti

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Silvia Colucci

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

Luciano Cavallo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

publication date

4 July 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

Expert review of endocrinology & metabolism

22 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

page(s)

525-534

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

Follicle-stimulating hormone promotes RANK expression on human monocytes

22 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Postmenopausal osteoporosis: the role of immune system cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Current concepts in pediatric bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Optimizing bone health and calcium intakes of infants, children, and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Bone health in children and adolescents with chronic diseases that may affect the skeleton: the 2013 ISCD Pediatric Official Positions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Bone densitometry in pediatric populations: discrepancies in the diagnosis of osteoporosis by DXA and CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Overdiagnosis of osteoporosis in children due to misinterpretation of dual-energy x-ray absorptiometry (DEXA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Cross-sectional reference data for phalangeal quantitative ultrasound from early childhood to young-adulthood according to gender, age, skeletal growth, and pubertal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Quantitative computed tomography (QCT) of the forearm using general purpose spiral whole-body CT scanners: accuracy, precision and comparison with dual-energy X-ray absorptiometry (DXA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Quantitative ultrasound in the management of osteoporosis: the 2007 ISCD Official Positions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Assessment of Bone Quality by Quantitative Ultrasound of Proximal Phalanges of the Hand and Fracture Rate in Children and Adolescents with Bone and Mineral Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Glucocorticoid-induced osteoporosis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Glucocorticoid-induced osteoporosis in children with 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Reductions in bone turnover, mineral, and structure associated with mechanical properties of lumbar vertebra and femur in glucocorticoid-treated growing minipigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Congenital adrenal hyperplasia due to 21 hydroxylase deficiency: from birth to adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Osteoclastogenesis in children with 21-hydroxylase deficiency on long-term glucocorticoid therapy: the role of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin imbalance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Inflammatory bowel disease and the risk of fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Long-term outcome of children with steroid-sensitive idiopathic nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Osteoporosis, genetics and hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

A school-curriculum-based exercise intervention program for two years in pre-pubertal girls does not influence hip structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

The reduction of physical activity reflects on the bone mass among young females: a follow-up study of 142 adolescent girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

High-protein intake enhances the positive impact of physical activity on BMC in prepubertal boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Effects of calcium supplementation on bone density in healthy children: meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Prevention of rickets and vitamin D deficiency in infants, children, and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Short- and long-term safety of weekly high-dose vitamin D3 supplementation in school children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Vitamin D deficiency in children and its management: review of current knowledge and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Bisphosphonates: the first 40 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

21 January 2018

Osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Clinical review 1: Bisphosphonate use in childhood osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Intravenous zoledronic Acid given every 6 months in childhood osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Six monthly intravenous zoledronic acid in childhood osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Alendronate affects long bone length and growth plate morphology in the oim mouse model for Osteogenesis Imperfecta

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Effects of teriparatide, alendronate, or both in women with postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Assessing the effect of baseline status of serum bone turnover markers and vitamin D levels on efficacy of teriparatide 20 μg/day administered subcutaneously in Japanese patients with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Teriparatide or alendronate in glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Teriparatide increases the maturation of circulating osteoblast precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Osteosarcoma in Sprague-Dawley rats after long-term treatment with teriparatide (human parathyroid hormone (1-34)).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

rhGH treatment in corticosteroid-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Oxandrolone Improves Height Velocity and BMI in Patients with Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Studies of anabolic steroids. 3. The effect of oxandrolone on height and skeletal maturation in mongoloid children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Effects of long-term oxandrolone administration in severely burned children

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

The effects of oxandrolone and exercise on muscle mass and function in children with severe burns

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Androgen receptor modulation does not affect longitudinal growth of cultured fetal rat metatarsal bones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Growth hormone secretion in Turner's syndrome and influence of oxandrolone and ethinyl oestradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Status of drug development for the prevention and treatment of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

Romosozumab in Postmenopausal Women with Osteopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

High-Dose Vitamin D Supplementation in Children with Cerebral Palsy or Neuromuscular Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F17446651.2014.936384

10.1586/17446651.2014.936384

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30736214%20AND%20SRC:MED&resulttype=core&format=json

22 April 2020

1 reference